New York University

New York University, doing business as New York University School of Medicine, operates as the medical and research arm of a major private research university, functioning as a prime recipient of federal research grants and a prime contractor for specialized clinical services, with no set-aside posture across its federal footprint. The School of Medicine competes full-and-open for grants from the National Institutes of Health, the Department of Veterans Affairs, and other federal agencies on the basis of scientific and clinical merit.

NYU School of Medicine's federal activity centers on biomedical and clinical research across the life sciences and healthcare. The core capability portfolio spans basic neuroscience, immunology, cancer biology, cardiovascular research, infectious disease, aging and dementia, maternal and child health, and specialized clinical services—cardiothoracic and perfusionist services, interventional radiology, and radiation safety delivered to the VA system. Recent prime contract work includes a $62.6 million firm fixed-price delivery order with Veterans Integrated Service Network 2 for cardiothoracic and perfusionist services through September 2034; a $10.5 million interventional radiology physician services contract with VISN 2 through August 2026; and a $1.2 million radiation safety services contract, also with VISN 2, through March 2026. Federal grant work dominates the profile: 2,891 prime awards (82% of the total) span project grants, cooperative agreements, and training programs from NIH institutes and centers, the Defense Health Agency, the National Science Foundation, and other agencies.

Customer concentration is high in research funding. The Department of Health and Human Services National Institutes of Health accounts for the largest share by award volume, with the National Institute on Aging, the National Institute of Allergy and Infectious Diseases, the National Heart Lung and Blood Institute, the National Institute of Child Health and Human Development, and the National Cancer Institute as repeat customers. The Department of Veterans Affairs Veterans Health Administration (Veterans Integrated Service Network 2) anchors clinical service delivery with $187.5 million in combined potential value across 45 awards—representing 32% of the School of Medicine's total potential value. The NIDA, the National Institute of Child Health and Human Development, and the National Institute of Environmental Health Sciences round out the top funders by dollar value.

Activity has grown substantially: 237 awards in 2023, escalating to 376 in 2024 before moderating to 251 in 2026. Awards reaching ultimate completion in the next twenty-four months carry combined potential value of $5.7 million, representing a modest recompete exposure. SCI-reported federal service contracting invoicing ran $7.9 million in FY2025 across 45.5 FTEs on the prime side, with an average sub-hours share of zero percent—the School of Medicine self-performs reported service-contract work rather than subcontracting. Government-paid hourly rates on SCI-reportable prime contracts span a median of $153.48/hr, with senior clinical and research labor pricing to $417.85/hr at the ninety-fifth percentile.

The School of Medicine holds no multi-year GWACs, BPAs, or agency-wide IDIQs in the classical federal contracting sense; its federal engagement is almost entirely through grant awards from NIH institutes and direct clinical service contracts with the VA, typically on a delivery-order basis under standing agreements such as indefinite delivery contracts VA24013D0049 (25 task orders, $601 thousand combined potential value) and 36C24E19D0016 (14 task orders, $777 thousand combined potential value). Federal grant work is distributed across Alzheimer's disease and aging research, cancer biology and treatment, cardiovascular disease, infectious disease, mental health, child health, and neurological disorders, with award periods typically three to five years. Representative recent prime grants include the National Institute on Aging's $3.053 million award for the ARIC CARES caregiving networks study; the National Institute of Neurological Disorders and Stroke's $639.6 million award investigating visual hallucinations in Lewy body diseases; and the National Heart Lung and Blood Institute's $2.567 million project examining macrophage signaling and ischemic injury in diabetes. The School of Medicine also participates as a sub-recipient on multi-site clinical and research trials led by academic medical centers and consortia members such as the Johns Hopkins University, Duke University, the University of Pennsylvania, Vanderbilt University Medical Center, Columbia University, and others; the sub-award portfolio reflects coordination roles in longitudinal epidemiologic cohorts, clinical trials, and translational research projects anchored at these partner institutions.

The institutional structure positions the School of Medicine as the research and clinical education entity within New York University, a tax-exempt private university headquartered in New York. Federal engagement operates through the university's parent entity administrative apparatus and through direct departmental and institutional awards, with no distinct subsidiaries or separate contracting entities. The School of Medicine's federal footprint reflects the characteristics of a major academic medical center: high-volume grant participation across NIH institutes; specialized clinical service contracting with the VA; full-and-open competition without set-aside reliance; a trajectory of sustained growth in research portfolio size; and a model of self-performed research and clinical delivery rather than a subcontracting-dependent supply chain.